Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL671704 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL27918671 | 0.94 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL249847 | 0.94 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL5157555 | 0.83 | RELA (0.53) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL5157560 | 0.83 | RELA (0.53) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL8651744 | 0.83 | NPC1 (0.59) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217829 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL1405466 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217840 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217836 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12402638-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-09-02 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-12232516-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-02-25 | — | — | US | claimed |
| US-12193465-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-01-14 | — | — | US | claimed |
| US-20240383170-A1 | FLEXIBLE AND SMART WOOD WITH RESPONSIVE FUNCTION, PREPARATION METHOD THEREOF AND ACTUATOR | NANJING FORESTRY UNIVERSITY (CN) | 2024-11-21 | — | — | US | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| CN-112592494-B | Preparation method of targeted colon part antibacterial imaging nano material based on dendritic cationic polyamide and tetraphenylethylene | 天津理工大学 | 2022-08-02 | — | — | CN | claimed |
| CN-112592494-A | Preparation method of targeted colon part antibacterial imaging nano material based on dendritic cationic polyamide and tetraphenylethylene | 天津理工大学 | 2021-04-02 | — | — | CN | claimed |
| EP-2368558-A1 | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch (DE) | 2011-09-28 | — | — | EP | claimed |
| EP-0389437-B1 | Luciferin derivatives | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1995-05-24 | — | — | EP | claimed |
| EP-4077464-B1 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC DESOTO INT INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12559593-B2 | Dual cure sealants | PRC-DESOTO INTERNATIONAL, INC. (CA) | 2026-02-24 | — | — | US | disclosed |
| US-12402638-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| EP-0389437-B1 | Luciferin derivatives | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1995-05-24 | — | — | EP | disclosed |
| US-5376556-A | Surface-enhanced Raman spectroscopy immunoassay | ABBOTT LABORATORIES (US) | 1994-12-27 | — | — | US | disclosed |
| EP-0587008-A1 | Surface-enhanced raman spectroscopy immunoassy | ABBOTT LABORATORIES (US) | 1994-03-16 | — | — | EP | disclosed |
| US-5266498-A | Ligand binding assay for an analyte using surface-enhanced scattering (SERS) signal | ABBOTT LABORATORIES (US) | 1993-11-30 | — | — | US | disclosed |
| US-5128069-A | Luciferin derivatives | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559593-B2 | Dual cure sealants | DUOX2, DUOX1, GPX4 | ALDH1A1 1456/4885TSHR 3920/4885MAPK1 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.